Oncology Programs

MDC-C1 (Radioisotope) for lung tumors

MDC-C1 actively targets unreachable lung tumors and significantly decreases lung tumor-burden (after single administration)

PET/SPCET/CT signal from the MDC-C1 confirmed its lung tumor targeting that was unreachable for standard options (18F-FDG)

Single administration of the MDC-C1 (both ALLOgeneic and AUTOlogous) highly significantly reduced lung tumor burden in mice.

MDC-C2 (drug) for lung tumors

MDC-C2 reaches higher drug concentration in the tumor-bearing lungs than drug administered according to current standards